Rolls-Royce and US company develop means for ultra cold vaccine transport in remote areas

A US-based innovation unit of UK-based global major industrial technology group Rolls-Royce has designed an ultra-low temperature cold transport pod for vaccines, a design that was then developed jointly with specialist US company ChefsFridge. The innovation team that designed the pod, which is named ArcticRx, is based in the Indianapolis area of the US state of Indiana, as is ChefsFridge. The ArticRx pod is intended specifically to transport vaccines that need to be kept at very low temperatures and administered in two doses. What makes it different is that it can maintain ultra-low temperatures for the long-term and in an entirely passive manner. It thus fills a gap in the vaccine transport chain, being intended for use in remote, rural and developing regions where electricity is unavailable. The ArcticRx is also lightweight and reusable, and can be refilled with more cooling materials.